Weight loss plateaus are common on a GLP-1 medication and usually reflect your body adapting not the medication stopping
Discuss the trade-offs between brand-name and compounded options with your prescriber
Further research examining body weight and cardiometabolic risk factors over an extended period of time such as 12month is warranted
Pricing is flat across doses, which protects you from escalation creep
Hedrick et al., 2006
Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R, McNary TJ, Churakova Y, Cheung C, Triscott J, Pisapia D, Rao R, Mosquera JM, Robinson B, Faltas BM, Emerling BE, Gadi VK, Bernard B, Elemento O, Beltran H, Demichelis F, Kemp CJ, Grandori C, Cantley LC, Rubin MA (2017) Personalized in vitro and in vivo Cancer models to guide precision medicine